Sun Pharma arm picks up 14.6% stake in US company for $13 million
"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment," Sun Pharmaceutical Industries said in a BSE filing.
Sun Pharma today said its subsidiary has invested $ 13 million (about Rs 88 crore) in the US-based scPharmaceuticals Inc.
"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment," Sun Pharmaceutical Industries said in a BSE filing.
It further said: "Consideration for Series B preferred stock acquired is $ 13 million."
ScPharmaceuticals Inc is a United States-based pharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.
The stock of Sun Pharma was trading 2.59% higher at Rs 625 on BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
12:37 PM IST
Sun Pharma drops 5% after US court halts launch of alopecia treatment drug
Sun Pharma Q2 Results Preview: PAT likely to grow 11.5%; gross margin may improve
FINAL TRADE: Sensex ends volatile session down 398 pts, Nifty slides to 24,918 dragged by energy, auto shares